Clinical Trial Update: Clinical, Molecular and by Neuroimaging of LRRK2 Mutations

View source ↗

Summary

A completed study evaluating clinical, molecular, and neuroimaging aspects of LRRK2 mutations in Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: Parkinson's Disease | Status: COMPLETED